Hidetomo Nakamoto

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study

Hitoshi Kumagai, Toshiya Ebata, Kenji Takamori et al. · Nephrology Dialysis Transplantation · 2009 · 348 citations · Full text

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)

Shigeru Nakai, Kazuyuki Suzuki, Ikuto Masakane et al. · Therapeutic Apheresis and Dialysis · 2010 · 228 citations

Dialysis, Renal Pathology, December 2008 +24

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD

Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara et al. · American Journal of Kidney Diseases · 2004 · 210 citations

Hypertension, Urology, Renal Function +8

Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)

Shigeru Nakai, Yuzo Watanabe, Ikuto Masakane et al. · Therapeutic Apheresis and Dialysis · 2013 · 196 citations · Full text

Dialysis, Dialysis Therapy, Dialysis Facilities +16

Encapsulating Peritoneal Sclerosis—A Clinician's Approach to Diagnosis and Medical Treatment

Hidetomo Nakamoto · Peritoneal Dialysis International · 2005 · 174 citations

Peritoneal Sclerosis, Medical Treatment, Opaque Tissue +11